Swedish Radio reported on the news.
It is at the Max Planck Institute in Berlin that Emmanuelle Charpentier and her research colleagues have for some time been trying to find a way to use Crispr-Cas9 to investigate how the coronavirus works.
- We had to play around quite a lot to be able to find the right conditions for infection and the right human lung cells that could grow well, to have a library of mutations for Crispr technology, says Emmanuelle Charpentier to Vetenskapsradion.
The study has not yet been published, but the researchers are said to have found several possible genes that the virus is believed to use.